Journal des médicaments en développement
Libre accès
ISSN: 2329-6631
ISSN: 2329-6631
Manuela Stoicescu
The main objective of this clinical-case-presentation is to attract attention that the therapy with Gabaran in high dosage and per long period of time without a careful control of function of pancreas (common dosage of amilasemia and amilasuria level) can develop unexpected severe acute pancreatitis and may put the patient’s life in danger.